AC Immune SA (ACIU) analyst actions
Rating and price-target actions on ACIU in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ACIU overview →
No ACIU analyst action events in the measured window.
Nothing matched in the current window — the ACIU overview has every event we measure for this name.
Get an email when ACIU moves on news →Keep exploring
More ACIU: earnings → · SEC filings → · ACIU overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | 198 | -0.18% | 44% |
| Stereotaxis, Inc. (STXS) | 197 | +0.11% | 51% |
| Daxor Corporation - Closed End Fund (DXR) | 196 | 0.00% | 49% |
| GENMAB A/S DKK (GNMSF) | 196 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.